Trial Profile
A Randomized, Double-Blind, Parallel-Arm, Placebo and Active Controlled Dose-Ranging Study of the Efficacy and Safety of Multiple Doses of CG5503 (Tapentadol) IR for Postoperative Pain Following Bunionectomy Surgery.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2009
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Oxycodone
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Janssen Research & Development
- 14 Nov 2009 Trial phase changed from III to II as reported by ClinicalTrials.gov.
- 23 May 2009 Actual patient number (480) added as reported by ClinicalTrials.gov.
- 13 Dec 2008 New trial record.